We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
CLEVELAND, March 18, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2023 and provided an update on progress toward achieving key...
CLEVELAND, March 05, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awa...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.73 | -9.45595854922 | 7.72 | 8.87 | 6.65 | 557057 | 7.65618775 | CS |
4 | -0.11 | -1.54929577465 | 7.1 | 9.01 | 6.16 | 472289 | 7.62676076 | CS |
12 | 1.99 | 39.8 | 5 | 9.01 | 4.0245 | 360446 | 6.37159385 | CS |
26 | 3.33 | 90.9836065574 | 3.66 | 9.01 | 3.6 | 245060 | 5.7344865 | CS |
52 | 4.61 | 193.697478992 | 2.38 | 9.01 | 2.24 | 196915 | 4.98549032 | CS |
156 | 4.81 | 220.642201835 | 2.18 | 9.01 | 0.1303 | 931284 | 1.24739268 | CS |
260 | -1.1 | -13.5970333745 | 8.09 | 9.01 | 0.1303 | 1207782 | 1.96559664 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |